Back

QRSarea as single indicator for selection of patients for resynchronization therapy: subanalysis of the RAFT study

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Novelties in cardiac resynchronisation therapy Cardiac Resynchronisation Therapy (CRT) EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Frits Prinzen

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Right ventricular septal pacing-derived V6 R-wave peak time predicts successful left bundle branch area pacing in patients with heart failure and left bundle branch block
Doctor M. Cai (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Safety and efficacy of conduction system pacing in dual-chamber pacemakers in a CRT-indicated population: primary analysis of the CORE-CPP study
Doctor K. Witte (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Lead V8 as a simple non-invasive tool for assessing lv activation delay across different conduction abnormalities
Mr J. van Koll (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Reverse remodelling in patients with cardiac resynchronisation therapy-defibrillator: comparison of a conventional 3-lead CRT-D and a 2-lead CRT-DX system with atrial sensing without atrial lead
Doctor G. Botto (Garbagnate Milanese, IT)
Abstract Slides Video
Presentation thumbnail
Personalized computational modelling of the electrical response to cardiac resynchronization strategies
Mr S. Gerrits (Maastricht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Novelties in cardiac resynchronisation therapy

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Session
Fighting ventricular dyssynchrony: cardiac resynchronisation therapy vs. conduction-system pacing
thumbnail
Congress Presentation
QRS index as a predictor of response to cardiac resynchronization therapy: a systematic review and meta-analysis
thumbnail
Congress Presentation
Cardiac resynchroniation therapy for non-LBBB and mid-range QRS: clinical value or questionable benefit?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources